Search - tctmd.com

Displaying 341 - 360 of 1103

Sort: Relevancy | Date

News Daily News

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

Yael L. Maxwell

March 01, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Daily News

Financial Strain Ups Risk of Death After Acute MI in the Elderly

L.A. McKeown

February 25, 2022

News Daily News

Fewer Diabetic Complications Seen When NOACs Given for AF

L.A. McKeown

February 22, 2022

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

News Daily News

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Yael L. Maxwell

February 17, 2022

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Michael O'Riordan

February 14, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Conference News ISC 2022

ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis

Todd Neale

February 10, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

L.A. McKeown

January 20, 2022

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

News Features

As COVID-19 Vaccine Boosters Roll Out to Younger Kids, Will Myocarditis Cases Rise?

Todd Neale

January 13, 2022

News Daily News

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Caitlin E. Cox

January 10, 2022

News Daily News

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

Caitlin E. Cox

January 07, 2022

News Daily News

Statins in Pregnancy Don’t Lead to Congenital Anomalies: Cohort Study

Yael L. Maxwell

January 03, 2022

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

Todd Neale

December 27, 2021

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Michael O'Riordan

December 23, 2021

News Daily News

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Michael O'Riordan

December 22, 2021

News Daily News

FDA Approves Two Additional Indications for Rivaroxaban in Children

L.A. McKeown

December 21, 2021

Advertisement

Recurrent Stroke Risk Lower With More Intense LDL-Lowering: Meta-analysis

March 2022 News Roundup

Financial Strain Ups Risk of Death After Acute MI in the Elderly

Fewer Diabetic Complications Seen When NOACs Given for AF

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Icosapent Ethyl Cost-effective Compared With Standard Care: REDUCE-IT

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

ACTION-CVT: DOACs Look Like a Good Option for Cerebral Venous Thrombosis

February 2022 News Roundup

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

As COVID-19 Vaccine Boosters Roll Out to Younger Kids, Will Myocarditis Cases Rise?

As US Diabetes Rates Soar, AHA Urges CV Risk Factor Control

Statins No Benefit to ICU-Admitted COVID-19 Patients: INSPIRATION-S

Statins in Pregnancy Don’t Lead to Congenital Anomalies: Cohort Study

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

FDA Approves Two Additional Indications for Rivaroxaban in Children

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content